1. Home
  2. IZEA vs ATOS Comparison

IZEA vs ATOS Comparison

Compare IZEA & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

HOLD

Current Price

$3.89

Market Cap

78.8M

ML Signal

HOLD

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$0.67

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IZEA
ATOS
Founded
2006
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.8M
83.3M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
IZEA
ATOS
Price
$3.89
$0.67
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
64.3K
1.5M
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,176,492.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.12
N/A
52 Week Low
$1.68
$0.55
52 Week High
$5.86
$1.29

Technical Indicators

Market Signals
Indicator
IZEA
ATOS
Relative Strength Index (RSI) 26.57 51.64
Support Level $3.86 $0.60
Resistance Level $4.01 $0.66
Average True Range (ATR) 0.16 0.05
MACD -0.02 0.01
Stochastic Oscillator 4.38 64.95

Price Performance

Historical Comparison
IZEA
ATOS

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: